Melatonin Market to Reach US$3.42 Billion by 2032 | Capsules Segment Leads with 35.4% Revenue Share in 2024 | DataM Intelligence

Leander, Texas and Tokyo, Japan - Nov 25, 2025
According to DataM Intelligence, the global melatonin market reached US$1.62 billion in 2023, rising to US$90.67 billion in 2024 and is expected to reach US$3.42 billion by 2032, growing at a CAGR of 9.8% from 2025 to 2032. This robust growth is propelled by increasing prevalence of sleep disorders, rising consumer awareness about sleep health, growing stress levels and hectic lifestyles, expanding applications in jet lag management and shift work disorder, and the growing preference for natural sleep aids over prescription medications.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/melatonin-market?jd

Browse in-depth TOC on "Melatonin Market"
81 - Tables
76 - Figures
210 - Pages

Recent Developments (November 2025)
✅ Natrol, LLC (US) launched an advanced capsule formulation with extended-release technology, specifically designed for sustained sleep support throughout the night for adult consumers.
✅ Church and Dwight Co., Inc. (US) expanded their melatonin gummy portfolio, introducing kid-friendly formats with precise dosing and appealing flavors for children's sleep support.
✅ NOW Foods (US) developed a high-potency liquid melatonin supplement, offering flexible dosing options and rapid absorption for immediate sleep onset benefits.
✅ Pfizer, Inc. (US) introduced a synthetic melatonin powder for pharmaceutical applications, achieving superior purity and consistency for clinical use in sleep disorder treatment.
✅ Nature's Bounty (US) launched a natural melatonin capsule line derived from plant sources, targeting health-conscious consumers seeking organic and natural sleep solutions.

Competitive Landscape
The market features strong competition between supplement companies, pharmaceutical manufacturers, and specialized health brands.

1. Natrol, LLC maintained market leadership with 26% global market share, expanding their capsule product line and reporting 28% revenue growth in 2024-2025 through strategic retail partnerships.
2. Church and Dwight Co., Inc. captured 22% market share in gummy formulations, securing dominant shelf presence in mass retail channels and achieving 25% growth through innovative delivery formats.
3. NOW Foods dominated the liquid segment with 20% market share, reporting 23% growth through expanded online distribution and consumer education initiatives.
4. Pfizer, Inc. led pharmaceutical-grade melatonin with 18% market share, achieving 21% growth through clinical validation and healthcare professional recommendations.
5. Nature's Bounty expanded their natural melatonin offerings with 16% market share, focusing on clean label products with 19% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/melatonin-market?jd

Segmentation Analysis
By Dosage Form
• Capsules dominates the market with 35.4% revenue share in 2024, projected to grow at 9.5% CAGR, valued for precise dosing, extended-release capabilities, ease of consumption, and established consumer preference among adult users seeking reliable sleep support.
• Liquid demonstrates significant expansion with 20% revenue share in 2024, growing at 10.8% CAGR, valued for rapid absorption and flexible dosing adjustments.
• Powder shows specialized applications in custom formulations and manufacturing.

By Source
• Synthetic Melatonin leads the market with 65% revenue share in 2024, growing at 9.2% CAGR, driven by cost-effectiveness, consistent quality, high purity levels, and widespread manufacturing scalability.
• Natural Melatonin shows robust growth with 35% revenue share in 2024, expanding at 11.5% CAGR, valued for clean label positioning, plant-derived origins, and appeal to health-conscious consumers.

By Distribution Channel
• Pharmacies and Drug Stores represents the largest segment with 32% revenue share in 2024, projected to grow at 9.1% CAGR, driven by consumer trust, professional availability, and healthcare recommendations.
• Online Stores shows strongest growth with 28% revenue share in 2024, expected to grow at 12.8% CAGR, preferred for convenience, product variety, and direct consumer access.
• Supermarkets & Hypermarkets and Convenience Stores demonstrate consistent retail presence and impulse purchasing.

By End-User
• Adults dominates the market with 78% revenue share in 2024, growing at 9.6% CAGR, driven by high stress levels, sleep disorders prevalence, and self-care awareness among working populations.
• Kids shows significant growth with 22% revenue share in 2024, expanding at 10.9% CAGR, supported by parental concerns about children's sleep quality and specialized pediatric formulations.

By Application
• Insomnia Treatment leads the market with 45% revenue share in 2024, projected to grow at 9.9% CAGR, driven by clinical validation and widespread consumer adoption for sleep initiation and maintenance.
• Jet Lag Management shows robust growth with 25% revenue share in 2024, expected to grow at 10.5% CAGR, valued by frequent travelers and business professionals.
• Stress Relief and Shift Work Disorder demonstrate expanding applications in modern lifestyle management.

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=melatonin-market

Regional Analysis:
North America dominates the melatonin market with 37.64% revenue share in 2024, driven by high consumer awareness about sleep health, strong supplement culture, widespread retail availability, significant stress levels, and established regulatory framework for supplement sales across the United States and Canada.

Asia-Pacific emerges as the fastest-growing region, projected to expand at 12.3% CAGR through 2032, fueled by rising disposable income, growing awareness about sleep disorders, expanding middle-class population, and increasing retail modernization across China, India, Japan, and Southeast Asian countries.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Market Trends & Drivers
The Melatonin Market is experiencing robust growth driven by the global sleep health crisis, increasing self-care trends, scientific validation of melatonin benefits, and expanding consumer demographics. Key trends include the development of innovative delivery formats, growth of pediatric-specific formulations, expansion into stress and mood applications, clean label and natural sourcing movements, and integration with digital health platforms. The sleep wellness movement, clinical research advancements, and consumer education are significantly contributing to market expansion.

Related Reports:
1. Sleep Aids Market - https://www.datamintelligence.com/research-report/sleep-aids-market?jd
2. Pharma and OTC Supplements Market - https://www.datamintelligence.com/research-report/pharma-and-otc-supplements-market?jd
3. Nutraceuticals Market - https://www.datamintelligence.com/research-report/nutraceuticals-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.